06:16 AM EST, 02/28/2025 (MT Newswires) -- Amneal Pharmaceuticals ( AMRX ) reported Q4 adjusted earnings Friday of $0.12 per diluted share, down from $0.14 a year earlier.

Four analysts polled by FactSet expected $0.15.

Revenue for the quarter ended Dec. 31 was $730.5 million compared with $617 million a year earlier.

Three analysts surveyed by FactSet expected $708.1 million.

The company said it expects 2025 adjusted EPS of $0.65 to $0.70 on revenue of $3 billion to $3.1 billion. Analysts surveyed by FactSet expect $0.71 and $2.92 billion, respectively.

Amneal shares were up 2.6% in recent premarket activity.